Alain Matagne
- Psychiatry and Mental health top 0.5%
- Cellular and Molecular Neuroscience top 0.5%
- Pediatrics, Perinatology and Child Health top 0.5%
- Molecular Biology top 10%
- Oncology top 10%
- Co-authors
- Henrik KlitgaardB. B. FuksBerkley A. LynchNathalie LambengPatricia Kensel-HammesKarl NockaSandra BajjaliehMichel Gillard
- Topics
- Epilepsy research and treatment (30 papers)Neuroscience and Neuropharmacology Research (29 papers)Pharmacological Effects and Toxicity Studies (16 papers)
- Cited by
- Psychiatry and Mental healthCellular and Molecular NeurosciencePediatrics, Perinatology and Child Health
- Journals
- Proceedings of the National Academy of SciencesBiochemical and Biophysical Research CommunicationsJournal of Medicinal Chemistry
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Alain Matagne
33 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Psychiatry and Mental health 2.5k
- Cellular and Molecular Neuroscience 2.2k
- Pediatrics, Perinatology and Child Health 1.8k
- Molecular Biology 800
- Oncology 268
Countries citing papers authored by Alain Matagne
This map shows the geographic impact of Alain Matagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Matagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Matagne more than expected).
Fields of papers citing papers by Alain Matagne
This network shows the impact of papers produced by Alain Matagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Matagne. The network helps show where Alain Matagne may publish in the future.
Co-authorship network of co-authors of Alain Matagne
This figure shows the co-authorship network connecting the top 25 collaborators of Alain Matagne. A scholar is included among the top collaborators of Alain Matagne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Matagne. Alain Matagne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 163 | |
| 2 | 32 | |
| 3 | 21 | |
| 4 | 93 | |
| 5 | 26 | |
| 6 | 8 | |
| 7 | 85 | |
| 8 | 185 | |
| 9 | Seletracetam (ucb 44212): Effect on inhibitory and excitatory neurotransmission | 3 |
| 10 | 46 | |
| 11 | 137 | |
| 12 | Brivaracetam Is A Potent Anticonvulsant In Experimental Status Epilepticus: 2.381 | 19 |
| 13 | 91 | |
| 14 | 60 | |
| 15 | 80 | |
| 16 | 36 | |
| 17 | 269 | |
| 18 | 7 | |
| 19 | 110 | |
| 20 | 213 |
About Alain Matagne
Alain Matagne is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health, having authored 33 papers that have together received 3.5k indexed citations. Recurring topics across this work include Epilepsy research and treatment (30 papers), Neuroscience and Neuropharmacology Research (29 papers) and Pharmacological Effects and Toxicity Studies (16 papers). The work is most often cited by research in Psychiatry and Mental health (2.5k citations), Cellular and Molecular Neuroscience (2.2k citations) and Pediatrics, Perinatology and Child Health (1.8k citations). Alain Matagne has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Henrik Klitgaard, B. B. Fuks, Berkley A. Lynch, Nathalie Lambeng, Patricia Kensel-Hammes, Karl Nocka, Sandra Bajjalieh, Michel Gillard, Rafał M. Kamiński and Benoît Kenda. Their work appears in journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.